The pharmaceutical industry’s fear of being hit with extremely high levies related to national security was soothed by President Donald Trump’s trade deal with the European Union, according to reports.

The trade agreement will impose a 15% tariff on imported medicines from Europe. That’s much lower than the taxes of up to 200% Trump had threatened, The New York Times reported.

Despite the lower percentage, the tariffs are expected to add billions of dollars in expenses for the drug industry, which may pass on charges to customers for some medicines, the Times added. That could mean higher out-of-pocket costs and higher health insurance premiums.

Read more at Newsmax© 2025 Newsmax. All rights reserved.